SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHCC Priority Healthcare -- Ignore unavailable to you. Want to Upgrade?


To: RockyBalboa who wrote (21)1/2/2001 7:15:48 PM
From: blebovits  Read Replies (1) | Respond to of 103
 
Priority Healthcare (PHCC:Nasdaq - news): DOWN to market outperform from trading buy at Morgan Stanley Dean Witter. The stock ended the trading day down $4.50, or 11%, to $36.31.

thestreet.com



To: RockyBalboa who wrote (21)1/23/2001 9:25:45 PM
From: blebovits  Read Replies (1) | Respond to of 103
 
Priority Healthcare Reiterated N-T `Accumulate' at Merrill
By Michael O. Donohue

Princeton, New Jersey, Jan. 22 (Bloomberg Data) -- Priority Healthcare Corp (PHCC US) was reiterated near-term ``accumulate'' by analyst David R. Risinger at Merrill Lynch. The 12-month target price is $38.00 per share. The long-term rating was reiterated ``buy.''

quote.bloomberg.com